tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

EOLS Stock Latest News

Evolus’s Jeuveau Growth and Resilience Amid Economic Uncertainties Supports Buy Rating
RatingsEvolus’s Jeuveau Growth and Resilience Amid Economic Uncertainties Supports Buy Rating
3d ago
EOLS
Optimistic Outlook for Evolus: Buy Rating Backed by Strategic Positioning and Strong Product Performance
PremiumRatings
Optimistic Outlook for Evolus: Buy Rating Backed by Strategic Positioning and Strong Product Performance
4d ago
EOLS
Evolus’s Strong Market Position and Growth Potential Highlighted by Robust Revenues and Strategic Expansions
PremiumRatings
Evolus’s Strong Market Position and Growth Potential Highlighted by Robust Revenues and Strategic Expansions
1M ago
EOLS
Evolus, Inc.: Navigating Financial Challenges Amidst Ongoing Losses and Market Uncertainty
PremiumCompany Announcements
Evolus, Inc.: Navigating Financial Challenges Amidst Ongoing Losses and Market Uncertainty
1M ago
EOLS
Evolus, Inc. Earnings Call Highlights Robust Growth and Profitability
PremiumCompany Announcements
Evolus, Inc. Earnings Call Highlights Robust Growth and Profitability
1M ago
EOLS
Evolus’s Promising Growth and Strategic Positioning Earns a ‘Buy’ Rating from Analyst Douglas Tsao
PremiumRatingsEvolus’s Promising Growth and Strategic Positioning Earns a ‘Buy’ Rating from Analyst Douglas Tsao
1M ago
EOLS
Evolus’s Promising Growth and Strategic Expansion Justify Buy Rating with $22 Price Target
Premium
Ratings
Evolus’s Promising Growth and Strategic Expansion Justify Buy Rating with $22 Price Target
1M ago
EOLS
Evolus price target raised to $25 from $22 at Barclays
Premium
The Fly
Evolus price target raised to $25 from $22 at Barclays
1M ago
EOLS
Evolus, Inc. Achieves Record Financial Growth in 2024
PremiumCompany Announcements
Evolus, Inc. Achieves Record Financial Growth in 2024
1M ago
EOLS
Closing Bell Movers: Crowdstrike down over 8% on soft guidance
PremiumThe Fly
Closing Bell Movers: Crowdstrike down over 8% on soft guidance
1M ago
BOX
ORN
Evolus reports Q4 EPS (11c) vs (21c) last year
PremiumThe Fly
Evolus reports Q4 EPS (11c) vs (21c) last year
1M ago
EOLS
Evolus sees FY25 revenue $345M-$355M, consensus $351.94M
PremiumThe Fly
Evolus sees FY25 revenue $345M-$355M, consensus $351.94M
1M ago
EOLS
EOLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsEOLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
EOLS
Evolus: Strategic Developments and FDA Approvals Drive Buy Rating with Promising Growth Projections
Premium
Ratings
Evolus: Strategic Developments and FDA Approvals Drive Buy Rating with Promising Growth Projections
2M ago
EOLS
Evolus Gains ‘Buy’ Rating: FDA Approval and Unique Technology Drive Growth Potential
Premium
Ratings
Evolus Gains ‘Buy’ Rating: FDA Approval and Unique Technology Drive Growth Potential
2M ago
EOLS
Evolus Gains Buy Rating on Early FDA Approval and Strategic Market Positioning
PremiumRatings
Evolus Gains Buy Rating on Early FDA Approval and Strategic Market Positioning
2M ago
EOLS
Evolus’s Strategic Advancements and Early FDA Approval Boost Growth Potential
PremiumRatings
Evolus’s Strategic Advancements and Early FDA Approval Boost Growth Potential
2M ago
EOLS
Evolus trading resumes
PremiumThe Fly
Evolus trading resumes
2M ago
EOLS
Evolus announces FDA approval of Evolysse products
PremiumThe Fly
Evolus announces FDA approval of Evolysse products
2M ago
EOLS
Evolus trading halted, news pending
PremiumThe FlyEvolus trading halted, news pending
2M ago
EOLS
Evolus price target raised to $22 from $20 at Barclays
Premium
The Fly
Evolus price target raised to $22 from $20 at Barclays
3M ago
EOLS
TikTok comes back online in U.S., Schwab reports Q4 beat: Morning Buzz
Premium
The Fly
TikTok comes back online in U.S., Schwab reports Q4 beat: Morning Buzz
3M ago
GM
DHI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >